APO Research
Talk to an analyst

APO RESEARCH · REPORT

Amisulpride Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Amisulpride Tablets Market Outlook and Growth Opportunities 2026

26 December 2025195 pages

Choose your research edition.

Industry ResearchAmisulpride Tablets Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Amisulpride Tablets Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Amisulpride Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Amisulpride Tablets Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Amisulpride Tablets Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Amisulpride Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Amisulpride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Amisulpride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Amisulpride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Amisulpride Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Amisulpride Tablets market include Zhejiang Huahai Pharmaceutical, Jewim Pharmaceutical, Sanofi and Qilu pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Amisulpride Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Amisulpride Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Amisulpride Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Amisulpride Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Amisulpride Tablets Segment by Company

Zhejiang Huahai Pharmaceutical

Jewim Pharmaceutical

Sanofi

Qilu pharmaceutical

Amisulpride Tablets Segment by Type

100mg

200mg

Others

Amisulpride Tablets Segment by Application

Hospital

Clinic

Others

Amisulpride Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Amisulpride Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Amisulpride Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Amisulpride Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Amisulpride Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amisulpride Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Amisulpride Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amisulpride Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Amisulpride Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Amisulpride Tablets industry.

Chapter 3: Detailed analysis of Amisulpride Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Amisulpride Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Amisulpride Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Amisulpride Tablets Industry Trends Table 2. Amisulpride Tablets Industry Drivers Table 3. Amisulpride Tablets Industry Opportunities and Challenges Table 4. Amisulpride Tablets Industry Restraints Table 5. Global Amisulpride Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Amisulpride Tablets Revenue Share by Company (2021-2026) Table 7. Global Amisulpride Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Amisulpride Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Amisulpride Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Amisulpride Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Amisulpride Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Amisulpride Tablets Company, Product Type & Application Table 13. Global Amisulpride Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Amisulpride Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 100mg Table 18. Significant Companies of 200mg Table 19. Significant Companies of Others Table 20. Global Amisulpride Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Amisulpride Tablets Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Amisulpride Tablets Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Amisulpride Tablets Sales Volume Share by Type (2021-2026) Table 24. Global Amisulpride Tablets Sales Volume Share by Type (2027-2032) Table 25. Global Amisulpride Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Amisulpride Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Amisulpride Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Amisulpride Tablets Sales Value Share by Type (2021-2026) Table 29. Global Amisulpride Tablets Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinic Table 32. Significant Companies of Others Table 33. Global Amisulpride Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Amisulpride Tablets Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Amisulpride Tablets Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Amisulpride Tablets Sales Volume Share by Application (2021-2026) Table 37. Global Amisulpride Tablets Sales Volume Share by Application (2027-2032) Table 38. Global Amisulpride Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Amisulpride Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Amisulpride Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Amisulpride Tablets Sales Value Share by Application (2021-2026) Table 42. Global Amisulpride Tablets Sales Value Share by Application (2027-2032) Table 43. Global Amisulpride Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Amisulpride Tablets Sales by Region (2021-2026) & (K Units) Table 45. Global Amisulpride Tablets Sales Market Share by Region (2021-2026) Table 46. Global Amisulpride Tablets Sales by Region (2027-2032) & (K Units) Table 47. Global Amisulpride Tablets Sales Market Share by Region (2027-2032) Table 48. Global Amisulpride Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Amisulpride Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Amisulpride Tablets Sales Value Share by Region (2021-2026) Table 51. Global Amisulpride Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Amisulpride Tablets Sales Value Share by Region (2027-2032) Table 53. Global Amisulpride Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Amisulpride Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Amisulpride Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Amisulpride Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Amisulpride Tablets Sales by Country (2021-2026) & (K Units) Table 58. Global Amisulpride Tablets Sales Market Share by Country (2021-2026) Table 59. Global Amisulpride Tablets Sales by Country (2027-2032) & (K Units) Table 60. Global Amisulpride Tablets Sales Market Share by Country (2027-2032) Table 61. Global Amisulpride Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Amisulpride Tablets Sales Value Market Share by Country (2021-2026) Table 63. Global Amisulpride Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Amisulpride Tablets Sales Value Market Share by Country (2027-2032) Table 65. Zhejiang Huahai Pharmaceutical Company Information Table 66. Zhejiang Huahai Pharmaceutical Business Overview Table 67. Zhejiang Huahai Pharmaceutical Amisulpride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Zhejiang Huahai Pharmaceutical Amisulpride Tablets Product Portfolio Table 69. Zhejiang Huahai Pharmaceutical Recent Development Table 70. Jewim Pharmaceutical Company Information Table 71. Jewim Pharmaceutical Business Overview Table 72. Jewim Pharmaceutical Amisulpride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Jewim Pharmaceutical Amisulpride Tablets Product Portfolio Table 74. Jewim Pharmaceutical Recent Development Table 75. Sanofi Company Information Table 76. Sanofi Business Overview Table 77. Sanofi Amisulpride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Sanofi Amisulpride Tablets Product Portfolio Table 79. Sanofi Recent Development Table 80. Qilu pharmaceutical Company Information Table 81. Qilu pharmaceutical Business Overview Table 82. Qilu pharmaceutical Amisulpride Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Qilu pharmaceutical Amisulpride Tablets Product Portfolio Table 84. Qilu pharmaceutical Recent Development Table 85. Key Raw Materials Table 86. Raw Materials Key Suppliers Table 87. Amisulpride Tablets Distributors List Table 88. Amisulpride Tablets Customers List Table 89. Research Programs/Design for This Report Table 90. Authors List of This Report Table 91. Secondary Sources Table 92. Primary Sources List of Figures Figure 1. Amisulpride Tablets Product Image Figure 2. Global Amisulpride Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Amisulpride Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Amisulpride Tablets Sales (2021-2032) & (K Units) Figure 5. Global Amisulpride Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Amisulpride Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 100mg Image Figure 10. 200mg Image Figure 11. Others Image Figure 12. Global Amisulpride Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Amisulpride Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Amisulpride Tablets Sales Volume Share by Type (2021-2032) Figure 15. Global Amisulpride Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Amisulpride Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Amisulpride Tablets Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Others Image Figure 21. Global Amisulpride Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Amisulpride Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Amisulpride Tablets Sales Volume Share by Application (2021-2032) Figure 24. Global Amisulpride Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Amisulpride Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Amisulpride Tablets Sales Value Share by Application (2021-2032) Figure 27. Global Amisulpride Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Amisulpride Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Amisulpride Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Amisulpride Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Amisulpride Tablets Sales Value (2021-2032) & (US$ Million) Figure 32. North America Amisulpride Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Amisulpride Tablets Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Amisulpride Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Amisulpride Tablets Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Amisulpride Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Amisulpride Tablets Sales Value (2021-2032) & (US$ Million) Figure 38. South America Amisulpride Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Amisulpride Tablets Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Amisulpride Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Amisulpride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Amisulpride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Amisulpride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Amisulpride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Amisulpride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Amisulpride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Amisulpride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Amisulpride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Amisulpride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Amisulpride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Amisulpride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Amisulpride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Amisulpride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Amisulpride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Amisulpride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Amisulpride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Amisulpride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Amisulpride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Amisulpride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Amisulpride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Amisulpride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Amisulpride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Amisulpride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Amisulpride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Amisulpride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Amisulpride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Amisulpride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Amisulpride Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Amisulpride Tablets Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Amisulpride Tablets Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg
  • 200mg
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Zhejiang Huahai Pharmaceutical
  • Jewim Pharmaceutical
  • Sanofi
  • Qilu pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Amisulpride Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Amisulpride Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Amisulpride Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Amisulpride Tablets Market Dynamics
  1. 2.1 Amisulpride Tablets Industry Trends
  2. 2.2 Amisulpride Tablets Industry Drivers
  3. 2.3 Amisulpride Tablets Industry Opportunities and Challenges
  4. 2.4 Amisulpride Tablets Industry Restraints
3 Amisulpride Tablets Market by Company
  1. 3.1 Global Amisulpride Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Amisulpride Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Amisulpride Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Amisulpride Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Amisulpride Tablets Company Ranking (2024-2026)
  6. 3.6 Global Amisulpride Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Amisulpride Tablets Company Product Type and Application
  8. 3.8 Global Amisulpride Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Amisulpride Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Amisulpride Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Amisulpride Tablets Market by Type
  1. 4.1 Amisulpride Tablets Type Introduction
  2. 4.1.1 100mg
  3. 4.1.2 200mg
  4. 4.1.3 Others
  5. 4.2 Global Amisulpride Tablets Sales Volume by Type
  6. 4.2.1 Global Amisulpride Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Amisulpride Tablets Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Amisulpride Tablets Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Amisulpride Tablets Sales Value by Type
  10. 4.3.1 Global Amisulpride Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Amisulpride Tablets Sales Value by Type (2021-2032)
  12. 4.3.3 Global Amisulpride Tablets Sales Value Share by Type (2021-2032)
5 Amisulpride Tablets Market by Application
  1. 5.1 Amisulpride Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Amisulpride Tablets Sales Volume by Application
  6. 5.2.1 Global Amisulpride Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Amisulpride Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Amisulpride Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Amisulpride Tablets Sales Value by Application
  10. 5.3.1 Global Amisulpride Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Amisulpride Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Amisulpride Tablets Sales Value Share by Application (2021-2032)
6 Amisulpride Tablets Regional Sales and Value Analysis
  1. 6.1 Global Amisulpride Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Amisulpride Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Amisulpride Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Amisulpride Tablets Sales by Region (2027-2032)
  5. 6.3 Global Amisulpride Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Amisulpride Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Amisulpride Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Amisulpride Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Amisulpride Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Amisulpride Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Amisulpride Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Amisulpride Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Amisulpride Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Amisulpride Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Amisulpride Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Amisulpride Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Amisulpride Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Amisulpride Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Amisulpride Tablets Sales Value Share by Country, 2025 VS 2032
7 Amisulpride Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Amisulpride Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Amisulpride Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Amisulpride Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Amisulpride Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Amisulpride Tablets Sales by Country (2027-2032)
  6. 7.4 Global Amisulpride Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Amisulpride Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Amisulpride Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Amisulpride Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Amisulpride Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Amisulpride Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Amisulpride Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Amisulpride Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Amisulpride Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Amisulpride Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Amisulpride Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Amisulpride Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Amisulpride Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Amisulpride Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Amisulpride Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Amisulpride Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Amisulpride Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Amisulpride Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Amisulpride Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Amisulpride Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Amisulpride Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Amisulpride Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Amisulpride Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Amisulpride Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Amisulpride Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Amisulpride Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Amisulpride Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Amisulpride Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Amisulpride Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Amisulpride Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Amisulpride Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Amisulpride Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Amisulpride Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Huahai Pharmaceutical
  2. 8.1.1 Zhejiang Huahai Pharmaceutical Company Information
  3. 8.1.2 Zhejiang Huahai Pharmaceutical Business Overview
  4. 8.1.3 Zhejiang Huahai Pharmaceutical Amisulpride Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Huahai Pharmaceutical Amisulpride Tablets Product Portfolio
  6. 8.1.5 Zhejiang Huahai Pharmaceutical Recent Developments
  7. 8.2 Jewim Pharmaceutical
  8. 8.2.1 Jewim Pharmaceutical Company Information
  9. 8.2.2 Jewim Pharmaceutical Business Overview
  10. 8.2.3 Jewim Pharmaceutical Amisulpride Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Jewim Pharmaceutical Amisulpride Tablets Product Portfolio
  12. 8.2.5 Jewim Pharmaceutical Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Amisulpride Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Amisulpride Tablets Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Qilu pharmaceutical
  20. 8.4.1 Qilu pharmaceutical Company Information
  21. 8.4.2 Qilu pharmaceutical Business Overview
  22. 8.4.3 Qilu pharmaceutical Amisulpride Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Qilu pharmaceutical Amisulpride Tablets Product Portfolio
  24. 8.4.5 Qilu pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Amisulpride Tablets Value Chain Analysis
  2. 9.1.1 Amisulpride Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Amisulpride Tablets Sales Mode & Process
  6. 9.2 Amisulpride Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Amisulpride Tablets Distributors
  9. 9.2.3 Amisulpride Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst